Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide-Reference-Cited by-同舟云学术

Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide

Published:2018-02-09 Issue:12 Volume:142 Page:2471-2477
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Maucort-Boulch Delphine¹²³⁴,de Martel Catherine⁵^ORCID,Franceschi Silvia⁵,Plummer Martyn⁵^ORCID

Affiliation:

1. Service de Biostatistique et Bioinformatique; Hospices Civils de Lyon; Lyon France

2. Université de Lyon; Lyon France

3. Université Lyon 1; Villeurbanne France

4. CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé; Villeurbanne France

5. International Agency for Research on Cancer; Lyon France

Funder

Fondation de France

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31280/fullpdf

Reference21 articles.

1. Ferlay J Soerjomataram I Ervik M 2013 http://globocan.iarc.fr/

2. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma-focus on East and South-Eastern Asia;Shin;Asian Pacific J Cancer Prevent,2010

3. Biological agents;IARC;IARC Monogr Eval Carcinog Risks Hum,2012

4. Association between liver fluke infection and hepatobiliary pathological changes: a systematic review and meta-analysis;Xia;PLoS One,2015

5. Hepatocellular carcinoma epidemiology;Bosetti;Best Pract Res Clin Gastroenterol,2014

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Mortality;International Encyclopedia of Public Health;2025

2. Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies;Annals of Hepatology;2024-11

3. Implementing a new HCV model of care for people who use drugs;JHEP Reports;2024-10

4. Comparison of the diagnostic performance of two PIVKA-II assays using the GALAD and ASAP algorithms for detecting hepatocellular carcinoma in Chinese patients;2024-09-10

5. Relevance of harmful intratumoral microbiota in cancer progression and its clinical application;Biomedicine & Pharmacotherapy;2024-09